About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Managing Hematologic Toxicities From Immunotherapeutic Agents
By
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
FEATURING
Michael Jaglal
By
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
FEATURING
Michael Jaglal
284 views
February 14, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Videos
38:56
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate on the Use of MRD to Guide Transplant D…
Feat.
H. Fernandez,
N. Bejanyan
31:09
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Updates on BCMA CAR T-Cell for MM: Real World Experience and Fu…
Feat.
M. Alsina
26:02
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Novel Immune-Based Therapy for R/R MM: Interactive Case Discuss…
Feat.
J. Brayer
16:00
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: How Much Is Too Much in NDMM - Triplet…
Feat.
R. Baz
18:44
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: How Much Is Enough in NDMM - Triplet …
Feat.
K. Shain
20:54
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Updates on COVID-19 in Cancer Patients: Outcomes and Prevention
Feat.
A. Giuliano
19:36
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Managing Hematologic Toxicities From Immunotherapeutic Agents
Feat.
M. Jaglal
23:05
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Evaluation of Clonal Hematopoiesis in Patients With Solid Tumors: Ca…
Feat.
E. Padron
22:37
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Moffitt Cancer Center Updates on the Role of CAR T-Cells in Lym…
Feat.
F. Locke
26:22
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 State of the Art: Best Frontline Therapy for CLL
Feat.
J. Pinilla-Ibarz
25:53
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center's Updates on Treatment of R/R DLBCL: Inte…
Feat.
S. Gaballa
34:29
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: Should NGS Be Reported in All Newly Di…
Feat.
B. Shah,
H. Saeed
27:27
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 State of the Art Frontline Management of the HR-MDS
Feat.
R. Komrokji
22:48
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Using Molecular Monitoring to Guide Therapy in AML: Interactive Case…
Feat.
K. Sweet